These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8259090)

  • 1. Contribution to problems of pseudohypoaldosteronism type I in children.
    Bayer M; Kutílek S
    Med Hypotheses; 1993 Sep; 41(3):277-8. PubMed ID: 8259090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kidney tubular transport disorders. Pseudohypoaldosteronism].
    Kinouchi T
    Nihon Rinsho; 1989 Jul; 47(7):1629-35. PubMed ID: 2810815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudohypoaldosteronism: Pathogenesis, pathophysiology, and therapy].
    Arai K; Shibasaki T
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():517-21. PubMed ID: 16523946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pseudohypoaldosteronism type I].
    Kaneko K
    Nihon Jinzo Gakkai Shi; 2011; 53(2):150-4. PubMed ID: 21516697
    [No Abstract]   [Full Text] [Related]  

  • 5. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Daumer C; Armanini D
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):597-605. PubMed ID: 2627754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence of mineralocorticoid receptors in peripheral lymphocytes: presence of receptor-like activity in patients with the autosomal dominant form of pseudohypoaldosteronism, and its absence in the recessive form.
    Kuhnle U; Keller U; Armanini D; Funder J; Krozowski Z
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):267-73. PubMed ID: 7826888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and children.
    Rodríguez-Soriano J; Ubetagoyena M; Vallo A
    Pediatr Nephrol; 1990 Mar; 4(2):105-10. PubMed ID: 2397174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normokalaemic pseudohypoaldosteronism is present in children with acute pyelonephritis.
    Rodríguez-Soriano J; Vallo A; Quintela MJ; Oliveros R; Ubetagoyena M
    Acta Paediatr; 1992 May; 81(5):402-6. PubMed ID: 1498506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mineralocorticoid receptor].
    Suzuki Y; Sekihara H
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():566-9. PubMed ID: 9172592
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient pseudohypoaldosteronism in obstructive renal disease with transient reduction of lymphocytic aldosterone receptors. Results in two affected infants.
    Kuhnle U; Guariso G; Sonega M; Hinkel GK; Hubl W; Armanini D
    Horm Res; 1993; 39(3-4):152-5. PubMed ID: 8262477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
    Zennaro MC; Fernandes-Rosa F
    J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
    Kuhnle U; Hinkel GK; Hubl W; Reichelt T
    Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Receptor-effector relations in the effect of adosterone on mononuclear leukocytes: validation and application to various water and electrolyte imbalances in humans].
    Wehling M
    Klin Wochenschr; 1989 Jan; 67(1):1-5. PubMed ID: 2537910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid resistance.
    Zennaro MC
    Steroids; 1996 Apr; 61(4):189-92. PubMed ID: 8732998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular update on pseudohypoaldosteronism type II.
    Pathare G; Hoenderop JG; Bindels RJ; San-Cristobal P
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1513-20. PubMed ID: 24107425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling.
    Proctor G; Linas S
    Am J Kidney Dis; 2006 Oct; 48(4):674-93. PubMed ID: 16997066
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pseudohypoaldosteronism.
    Popow C; Pollak A; Herkner K; Scheibenreiter S; Swoboda W
    Acta Paediatr Scand; 1988 Jan; 77(1):136-41. PubMed ID: 2967023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.